Kidney and liver kynurenine pathway enzymes in chronic renal failure

Advances in Experimental Medicine and Biology

Volumn 527, Issue , 2003, Pages 409-414

  Tankiewicz, Anna ^a   Pawlak, Dariusz ^b   Topczewska Bruns, Joanna ^b   Buczko, Wlodzimierz ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYKYNURENINE; ENZYME; INDOLEAMINE; KYNURENINE; KYNURENINE 3 MONOOXYGENASE; TRYPTOPHAN; TRYPTOPHAN 2,3 DIOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CHRONIC KIDNEY FAILURE; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EXCRETION; INTERMETHOD COMPARISON; KIDNEY FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 1042279502     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0135-0_48     Document Type: Conference Paper

References (22)

1. K. Saito, S. Fujigaki, M. P. Heyes, K. Shibata, M. Takemura, H. Fujii, H. Wada, A. Noma, M. Seishima, Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency, Am. J. Physiol. Renal Physiol. 279, F565-F572 (2000).
2. E.W. Holmes, P. Russell, G.J. Kinzler, C.R. Reckard, R.C. Flanigan, K.D. Thompson, E.W. Bermes, Oxidative tryptophan metabolism in renal allograft recipients: increased kynurenine synthesis is associated with inflammation and OKT3 therapy, Cytokine 4, 205-213 (1992).
3. W.M. Behan, T.W. Stone, Role of kynurenines in the neurotoxic actions of kainic acid, Br. J. Pharmacol. 129, 1764-1770 (2000).
4. V. Kapoor, R. Kapoor, J.P. Chalmers, Altered responsiveness of medullary depressor neurones to L-glutamate and D-serine in SHR rats, Neuroreport, 1, 1409-1412 (1996).
5. Y. Kawashima, T. Sanaka, N. Sugino, M. Takashashi, H. Mizoguchi, Supressive effect of quinolinic acid and hippuric acid on bone marrow erythroid grouth and lymphocyte blast formation in uremia, Adv. Exp. Med. Biol. 223, 69-72 (1987).
6. S. Berweck, I. Hennig, C. Sternberg, H. Dingerkus, K. Ludat, H. Hampl, Cardiac mortality prevention in uremic patients. Therapeutic strategies with particular attention to complete correction of renal anemia, Clin. Nephrol. 53, 80-85 (2000).
7. TW. Stone, Neuropharmacology of quinolinic and kynurenic acids, Pharmacol. Rev, 45, 309-379 (1993).
8. M.W. Taylor, G. Feng, Relationship between interferon-γ, indoleamine 2,3-dioxygenase, and tryptophan catabolism, FASEB J. 5, 2516-2522 (1991).
9. J. Breton, N. Avanzi, S. Magagnin, N. Covini, G. Magistrelli, L. Cozzi, A. Isacchi, Functional characterization and mechanism of action of recombinant human kynurenine 3-hydroxylase, Eur. J. Biochem. 267, 1092-1099 (2000).
10. D. Ormrod, T. Miller, Experimental uremia, Nephron 26, 249-2541 (1980).
11. C. Hevere, P. Beyne, H. Jamault, E. Delacoux, Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection, J. Chromatogr. 675, 157-161 (1996).
12. E.W. Holmes, Determination of serum kynurenine and hepatic tryptophan dioxygenase activity by high liquid chromatography, Anal. Biochem. 172, 518-525 (1988).
13. M.P. Heyes, Quantification of 3-hydroksykynurenine in brain by high-performance liquid chromatography and electrochemical detection, J. Chromatogr. 428, 340-344 (1988).
14. M. Salter, R. Hazelwood, C. Pogson, R. Iyer, D.J. Madge, The effect of a novel and selective inhibitor of tryptophan 2,3-dioxygenase on tryptophan and serotonin metabolism in the rat, Biochem Pharmacol 49, 1435-1442 (1995).
15. K. Saito, M.P. Heyes, Kynurenine pathway enzymes in brain. Properties of enzymes and regulation of quinolinic acid synthesis, in: Recent Advances in Tryptophan Research, edited by Graziella Allegri Filippini et al. (Plenum Press, New York, 1996), pp. 485-492.
16. E.W. Holmes, S.E. Kahan, Tryptophan distribution and metabolism in experimental chronic renal insufficiency, Exp. Mol. Pathol. 46, 89-101 (1987).
17. J. Topczewska-Bruns, A. Tankiewicz, D. Pawlak, W. Buczko, Behavioral changes in the course of chronic renal insufficiency in rats, Pol. J. Pharmacol. 53, 263-269 (2001).
18. A. Chiarugi, P. Sbarba, D. Paccagnini, S. Donnini, S. Filippi, F. Moroni, Combined inhibition of indoleamine 2,3-dioxygenase and nitric oxide synthetase modulates neurotoxin release by interferon-γ-activated macrophages, J. Leukocyte Biol. 68, 260-266 (2000).
19. F. Takeuchi, R. Tsubouchi, S. Izuta, Y. Shibata, Kynurenine metabolism and xanthurenic acid formation in vitamin B6-deficient rat after tryptophan injection, J. Nutr. Sci. Vitaminol. 35, 111-122 (1989).
20. A. Martinsons, V. Rudzite, V. Groma, O. Bratslavska, B. Widner, D. Fuchs, Kynurenine and neopterin in chronic glomerulonephritis. Adv. Exp. Med. Biol. 467, 72-77 (1999).
21. A. Martinsons, V. Rudzite, E. Jurika, A. Silava, The relationship between kynurenine, catecholoamines, and arterial hypertension in mesangioproliferative glomerulonephritis, Adv. Exp. Med. Biol. 398, 417-419 (1996).
22. A. Martinsons, V. Rudzite, O. Bratslavska, V. Saulite, The influence of kynurenine, and norepinephrine on tubular epithelial cells and alveolar fibroblasts, Adv. Exp. Med. Biol. 467, 347-352 (1999).